Octagon Capital Advisors LP Design Therapeutics, Inc. Transaction History

Octagon Capital Advisors LP

  • $433 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$13.64 - $21.41 $203,590 - $319,565
-14,926 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$13.99 - $20.03 $3.29 Million - $4.71 Million
-235,074 Reduced 94.03%
14,926 $219,000
Q1 2021

May 17, 2021
BUY
$29.52 - $41.49 $7.38 Million - $10.4 Million
250,000 New
250,000 $7.48 Million

Others Institutions Holding DSGN

# of Institutions
100
Shares Held
31.9M
Call Options Held
1.1K
Put Options Held
21.3K
View Full List

About Design Therapeutics, Inc.

DSGN Quotes by TradingView
  • Ticker DSGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,807,900
  • Market Cap $311M
  • Description
  • Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...
More about DSGN
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email